-
-
-
-
-
-
-
Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Updates
-
-
-
-
-
-
-
Monopar Partners with Seasoned Medtech Executive to Explore the Potential of MNPR-101 as a uPAR Imaging Agent in Cancer Surgery
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

